Detalhe da pesquisa
1.
Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection.
J Infect Dis
; 213(1): 31-8, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26142433
2.
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera.
NPJ Vaccines
; 9(1): 85, 2024 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38762525
3.
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays.
Sci Transl Med
; 16(747): eadl1722, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38748773
4.
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography.
Nat Commun
; 14(1): 5224, 2023 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633965
5.
Characterization of A/H7 influenza virus global antigenic diversity and key determinants in the hemagglutinin globular head mediating A/H7N9 antigenic evolution.
mBio
; 14(5): e0048823, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37565755
6.
Mapping SARS-CoV-2 antigenic relationships and serological responses.
bioRxiv
; 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35860221
7.
Mapping SARS-CoV-2 antigenic relationships and serological responses.
Science
; 382(6666): eadj0070, 2023 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37797027
8.
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera.
bioRxiv
; 2023 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37808679
9.
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants.
Nat Commun
; 13(1): 7701, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36513653
10.
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains.
Sci Transl Med
; 14(630): eabm3302, 2022 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34846168
11.
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains.
bioRxiv
; 2021 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462745
12.
Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant.
Vaccine
; 34(33): 3780-6, 2016 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27342914